Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 18, 2024
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
[ Mon, Mar 18th 2024
] - WOPRAI
Fri, March 15, 2024
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
Etzer Darout Maintained (TERN) at Buy with Increased Target to $19 on, Mar 15th, 2024
Etzer Darout of BMO Capital, Maintained "Terns Pharmaceuticals, Inc." (TERN) at Buy with Increased Target from $18 to $19 on, Mar 15th, 2024.
Etzer has made no other calls on TERN in the last 4 months.
There are 2 other peers that have a rating on TERN. Out of the 2 peers that are also analyzing TERN, 0 agree with Etzer's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Etzer
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $17 on, Tuesday, December 5th, 2023
- Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $10 on, Monday, November 27th, 2023
